Work

Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies

Year: 2022

Type: review

Source: Clinical and Experimental Dermatology

DOI: 10.1111/ced.15332

Authors: Riyad N. H. Seervai, Avilasha Sinha, Rajan P. Kulkarni

Institutions: Baylor College of Medicine, Providence Portland Medical Center, Oregon Health & Science University, Portland VA Medical Center, VA Portland Health Care System, OHSU Knight Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, American Cancer Society, Cancer Research Institute, Melanoma Research Alliance

Awards: CLINICAL AND BIOLOGICAL INSIGHT INTO MAPK SIGNALING AND TUMOR HETEROGENEITY USING CIRCULATING TUMOR BIOMARKERS, G2906302043, Evaluating Heterogeneity in Melanoma using Circulating Tumor Cells, EVALUATING HETEROGENEITY AND RESPONSE TO TREATMENT IN MELANOMA USING CIRCULATING TUMOR CELLS

OpenAlex ID: W4285732138

FWCI: 0.366

Cites: 116

Cited by: 16

Related to: 10